Teva Pharmaceutical reported 4.74B in Operating Expenses for its second fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Operating Expenses Change
Aspen Pharmacare APN:SJ 14.82B 758M
Cipla CIPLA:IN 44.86B 3.72B
Dr.Reddys Laboratories DRRD:IN 45.94B 7.23B
Guangzhou Baiy 600332:CH 18.28B 3.32B
Jiangsu Hengrui Me. 600276:CH 4.11B 2B
Kalbe Farma Tbk Pt KLBF:IJ 5842.96B 106.82B
Richter Gedeon RICHT:HB 141.65B 11.08B
Sh Fosun Pharma 600196:CH 9.49B 856.29M
Sun Pharmaceuticals SUNP:IN IR 86110.4M 31485.9M
Teva Pharmaceutical TEVA:IT 4.74B 361M